CNO Financial Group account plan
Life health insurance annuities
At a glance
CNO Financial Group is a US insurer for middle-income retirees (Bankers Life, Washington National, Colonial Penn) with $4.5 billion of 2025 revenues.
CNO Financial Group is a holding company, headquartered in Carmel, Indiana, for insurers that develop, market and administer health insurance, annuities and individual life insurance for middle-income pre-retiree and retired Americans. It sells under the Bankers Life, Washington National and Colonial Penn brands through a Consumer Division (about 4,600 producing exclusive agents plus a large direct-to-consumer business) and a Worksite Division. In 2025 it had revenues of $4.5 billion, net income of $229.3 million, net operating income of $439.2 million and about 3,300 full-time associates, with total assets of $38.8 billion. Gary C. Bhojwani has been CEO since January 2018.
Business units
Annuities
42 percent of 2025 premium collections ($1,943.3 million)Mainly fixed indexed annuities ($1,739.9 million of collections, up 12.8 percent) plus fixed interest annuities, sold only through captive distribution to middle-income savers. Annuity margin was $238.6 million in 2025; annuity collected premiums were $514 million in Q3 2026, up 9%.
Health
Supplemental health (16 percent of 2025 collections), Medicare supplement (14 percent) and short-duration long-term care (6 percent), producing the largest margin, $556.6 million in 2025. Medicare Supplement NAP rose 41% in Q3 2026 as consumers shift away from Medicare Advantage.
Life
21 percent of 2025 premium collections ($984.5 million)Traditional life (whole, graded benefit and term) and interest-sensitive universal life, with a 2025 margin of $272.4 million. Marketing is moving from television to web, digital and third-party channels.
Consumer Division
Serves individuals by phone, online and face to face through about 4,600 producing exclusive agents in about 230 branch and satellite offices plus one of the largest direct-to-consumer insurance businesses. Led by Scott L. Goldberg; career field agent NAP rose 13% in Q3 2026.
Worksite Division
Sells voluntary supplemental health and life insurance to employers, associations and membership groups through about 400 exclusive producing agents. Led by Karen J. DeToro; NAP rose 18% in Q3 2026, the eighth consecutive quarter of double-digit growth, after the exit from Worksite fee services (Optavise).
Strategic priorities
- Top-quartile ROE
- The target of a 200 basis point run-rate operating ROE improvement through 2027 is expected to be exceeded in 2026; the next goal is "to become a consistent top quartile player", with new targets due February 2027.
- Captive agent distribution
- Grow the exclusive agent force: 15th consecutive quarter of producing agent count growth in Q3 2026, with the career agency generating about 90% of Worksite insurance sales.
- Capture the Medicare Advantage to Medicare Supplement shift
- More than 3 million Medicare Advantage members must choose new coverage for 2027; Medicare is used as a door-opening product, with annuities deepening the relationship.
- TechMod technology modernization
- A three-year project started in 2025 to migrate to modernized insurance administrative platforms, with about $70 million of spend expected in 2026 and a comparable amount in 2027.
- Shift marketing off television
- Non-television channels generated 71% of direct-to-consumer life sales in Q3 2026 as advertising moves to web, digital and third-party channels.
- Focus on core insurance
- Exit of the Worksite fee services business, substantially complete as of June 30, 2026, to sharpen focus on the core insurance business.
Latest results
In Q3 2026 net operating income rose to $179.1 million from $127.2 million, or $134.2 million versus $95.0 million excluding significant items, and operating EPS rose 47%. Total net investment income rose 13 percent to $350.7 million, and the annual actuarial review added $56.3 million to insurance product margins. Medicare supplement margins were hit by higher morbidity, while long-term care and traditional life margins grew. Full-year 2026 operating EPS guidance was raised to $5.05 to $5.15 (previously $4.60 to $4.80), with an expense ratio of 18.6 to 18.8 percent and free cash flow of $220 to $240 million.
Investments and deals
- TechMod
- $20.3 million of expense in 2025 and $33.5 million of non-operating expense in the first nine months of 2026, mainly data conversion and migration to modernized administrative platforms.
- CNO Bermuda Re
- Reinsured $1.9 billion of supplemental health reserves from October 1, 2025 and about $270 million of Colonial Penn graded benefit life reserves from October 1, 2026; the planned in-force transactions are essentially complete.
- Optavise exit
- Exit from Worksite fee services announced November 2025, with a $101.9 million goodwill and other asset impairment.
- Share buybacks
- $319.9 million of buybacks in 2025 and $180.0 million in the first nine months of 2026.
Challenges and risks
- Medicare supplement morbidity
- Higher Q3 2026 morbidity hit Medicare supplement margins, with the adjusted margin at 17 percent versus 19 percent; a 10 percent increase in assumed morbidity would cut pre-tax income by $68 million.
- Falling Medicare Advantage fee income
- Medicare Advantage sales fell 17.6 percent in nine months of 2026 and fee income guidance was cut to about $25 million.
- Agent recruiting and retention
- The model depends on attracting and retaining agents and marketing organizations, against larger, higher-rated insurers and direct marketers.
- Interest rates and investment risk
- Rates and credit conditions affect the $30.0 billion portfolio and annuity spreads; about $3.9 billion of liabilities could be surrendered without penalty.
- Cyber and AI operational risk
- The 10-K lists cyber and IT interruption, AI-related operational risk and outsourcing among its risks.
What leadership says
“Our exclusive middle market focus and our last-mile captive agent distribution model are the foundation of our durable competitive moat.”
“There is a secular shift happening from Medicare Advantage to Medicare Supplement”
“As often as anything, our competition is a bank CD.”
“12% return on equity was not the destination but rather a waypoint”
Where a supplier can help
- Core platform migration and data conversion
- Tied to TechMod: data conversion, platform migration and consulting are the named cost lines of a programme spending about $70 million in 2026.
- Agent recruiting and productivity tools
- Tied to the captive agent distribution priority and the recruiting challenge: tools for recruiting, onboarding and equipping exclusive agents.
- Digital marketing and lead generation
- Tied to the shift off television: web, digital and third-party channels now drive most direct-to-consumer life sales.
- Medicare advice at scale
- Tied to the Medicare Advantage to Medicare Supplement shift: call-centre, quoting and enrolment tools for the 2027 coverage switch.
- Claims and morbidity analytics
- Tied to the Medicare supplement morbidity challenge: claims analytics and pricing tools to protect health margins.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like CNO Financial Group?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- CNO Financial Group Annual Report on Form 10-K for fiscal year 2025
- CNO Financial Group is a US holding company (Carmel, Indiana) for insurers that develop, market and administer health insurance, annuities and individual life insurance, focused on "middle-income pre-retiree and retired Americans"; brands Bankers Life, Washington National and Colonial Penn.
- FY2025: revenues of $4.5 billion, net income of $229.3 million ($2.30 per diluted share), net operating income of $439.2 million ($4.40 per diluted share, up from $3.97); total assets $38.8 billion; about 3,300 full-time associates.
- Premium collections of $4.6 billion: annuities $1,943.3 million (42%), life $984.5 million (21%), supplemental health $744.5 million (16%), Medicare supplement $626.8 million (14%), long-term care $292.2 million (6%).
- Sold through two divisions: Consumer (about 4,600 producing exclusive agents in about 230 branch and satellite offices, plus one of the largest direct-to-consumer insurance businesses) and Worksite (about 400 exclusive producing agents selling voluntary benefits to employers).
- Total insurance product margin $1,067.6 million: health $556.6 million, life $272.4 million, annuity $238.6 million; expense ratio improved to 18.9 percent from 19.2 percent.
- Strategic moves: exit of the Worksite fee services business (Optavise) announced November 2025, with a $101.9 million goodwill and other asset impairment; TechMod, a three-year technology modernization started in 2025 ($20.3 million of expense in 2025); CNO Bermuda Re reinsured $1.9 billion of supplemental health reserves from October 1, 2025.
- Target: improve run-rate operating ROE by 200 basis points through 2027 from a 2024 run-rate of about 10 percent; operating ROE excluding significant items was 11.4 percent in 2025.
- Medicare supplement sales were very strong in Q4 2025, reflecting a shift in consumer preference from Medicare Advantage to Medicare Supplement, "reversing a decade-long trend".
- Capital: RBC ratio 380 percent (target 360-390 percent), holding company free cash flow $365.5 million, $319.9 million of share buybacks (8.1 million shares) and $66.4 million of dividends.
- Key risks: interest rates and investment portfolio, adequacy of premium rates and reserves (Medicare supplement morbidity), dependence on agent recruiting and retention, ratings below many competitors, NOL preservation, cyber and AI-related operational risk.
- CNO Financial Group Quarterly Report on Form 10-Q for Q3 2026
- Q3 2026 net operating income $179.1 million versus $127.2 million in Q3 2025; nine-month net operating income $399.9 million versus $295.8 million; excluding significant items $134.2 million in the quarter versus $95.0 million.
- The Q3 2026 comprehensive annual actuarial review added $56.3 million to insurance product margins and $36.0 million to net income.
- Insurance product margin $333.0 million ($276.7 million excluding significant items, versus $259.2 million); total net investment income up 13 percent to $350.7 million.
- Guidance raised: 2026 operating EPS of $5.05 to $5.15 (previously $4.60 to $4.80), expense ratio 18.6 to 18.8 percent, fee income about $25 million, free cash flow $220 to $240 million.
- 2026 operating ROE expected to exceed the 12 percent target set for year-end 2027; operating ROE excluding significant items was 14.1 percent; new targets due February 2027.
- CNO Bermuda Re's third treaty reinsured about $270 million of graded benefit life reserves from Colonial Penn, effective October 1, 2026.
- Medicare Advantage sales fell 7.9 percent in the quarter and 17.6 percent in nine months on the continued shift toward Medicare supplement; Medicare supplement margin hit by higher Q3 morbidity.
- TechMod: $33.5 million of non-operating expense in nine months; about $70 million of spend expected in 2026.
- Capital: RBC ratio 374 percent; 3.8 million shares bought back for $180.0 million in nine months; $22.1 million valuation allowance on capital loss carryforwards.
- CNO Financial Group Q3 2026 Earnings Call Transcript
- CEO Gary Bhojwani: operating EPS up 47% in Q3 2026 and 43% year to date; 17th consecutive quarter of sales growth and 15th of producing agent count growth; full-year operating EPS guidance raised to $5.05-$5.15, up 9% at the midpoint.
- The moat: "Our exclusive middle market focus and our last-mile captive agent distribution model are the foundation of our durable competitive moat."
- Medicare: Medicare Supplement NAP up 41% in the quarter and more than 60% over 12 months; more than 3 million Medicare Advantage members must choose new coverage for 2027, which plays to CNO's advice-based model.
- Consumer: career field agent NAP up 13%, health NAP up 7%, life NAP down 9% against a prior-year $13 million third-party pilot (up 20% excluding it); annuity collected premiums $514 million, up 9%; client assets nearly $20 billion.
- Worksite: NAP up 18%, eighth consecutive quarter of double-digit growth; NAP from new clients up 168%; life sales up 59%.
- CFO Paul McDonough: expense ratio 18.5% on a trailing 12-month basis; operating ROE 14.1% excluding significant items; new money rate 6.24%, the 15th consecutive quarter above 6%.
- Bermuda: third treaty ceded about $270 million of Colonial Penn graded benefit life reserves; the planned in-force transactions are essentially complete, with 2027 focused on optimizing assets and capital there.
- TechMod cash spend of roughly $70 million in 2026 and a comparable amount expected in 2027.
- Bhojwani's goal: "to become a consistent top quartile player" on ROE; new long-term targets in February 2027.
- CNO Financial Group Q2 2026 Earnings Call Transcript
- CEO Gary Bhojwani: operating EPS up 45% in Q2 2026 and 43% year to date excluding significant items; 16th consecutive quarter of sales growth; total NAP up 7% with multiple sales records.
- CFO Paul McDonough: operating EPS $1.26; expense ratio 18.4%; trailing operating ROE 14.1%, 13.1% excluding significant items; full-year operating EPS guidance raised to $4.60-$4.80, up 8% at the midpoint.
- Medicare Supplement NAP up 52%, third consecutive quarter above 50%, driven by the shift away from Medicare Advantage; more than 11 thousand Americans turn 65 each day.
- Consumer: health NAP up 17%, life NAP down 9% on lower direct-to-consumer sales; record annuity collected premiums of $536 million; non-TV channels produced nearly 72% of D2C life sales.
- Worksite: record NAP up 29%; life up 44%; NAP from new clients up 84%; the career agency generates about 90% of Worksite insurance sales.
- 2026 operating ROE expected to exceed the 12% target set for year-end 2027; "12% return on equity was not the destination but rather a waypoint".
- Capital deployment unchanged: TechMod reinvestment, selective inorganic growth, dividends and buybacks; Bhojwani still thinks the company "is undervalued".
- Annuity competition: captive distribution and middle-income focus mean "As often as anything, our competition is a bank CD".
Questions about CNO Financial Group
What does CNO Financial Group do?
CNO's insurers sell health insurance, annuities and life insurance to middle-income pre-retiree and retired Americans under the Bankers Life, Washington National and Colonial Penn brands.
What was CNO's revenue in 2025?
Revenues were $4.5 billion in 2025, with net income of $229.3 million and net operating income of $439.2 million.
How many employees does CNO have?
About 3,300 full-time associates, nearly all in the United States, plus about 4,600 producing exclusive agents in the Consumer Division.
Who leads CNO Financial Group?
Gary C. Bhojwani has been CEO since January 2018 and Paul H. McDonough has been CFO since March 2019.
What is CNO's 2026 guidance?
Operating EPS of $5.05 to $5.15 excluding significant items, an expense ratio of 18.6 to 18.8 percent and free cash flow of $220 to $240 million.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)